Hydrochlorothiazide And Sun Sensitivity: What You Should Know Before Going Outdoors

August 25, 2025/Andrew Le

Many people take hydrochlorothiazide to manage high blood pressure. Yet few realize it can quietly change how the skin reacts to sunlight. What seems like a routine medication may leave you at risk of painful rashes, unusual sunburns, or even long-term damage. The concern grows because these reactions don’t always appear right away. They may show up after weeks, months, or even years of use. That makes it harder to notice the connection.

So, what happens when skin becomes more sensitive to the sun while on this drug? Studies link it not only to dermatitis, lupus, and chronic rashes but also to higher risks of skin cancers.

🔑 Key takeaways

➤ Hydrochlorothiazide can make skin more sensitive to the sun and increase the chance of damage.

➤ The drug may cause rashes, sunburn-like reactions, eczema, or even lupus in some people.

➤ Long-term use combined with high sun exposure raises the risk of certain skin cancers.

➤ Wearing sunscreen, protective clothing, and avoiding midday sun helps reduce these risks.

➤ Regular skin checks allow doctors to catch problems early and prevent serious issues.

➤ Noticing new rashes or itching after starting the drug is a signal to contact a doctor quickly.

How does hydrochlorothiazide affect the skin?

Hydrochlorothiazide (HCTZ) is a thiazide-type diuretic that has been in use for decades to treat hypertension. Yet, while it benefits the heart and kidneys, it also interacts with the skin in ways that raise concern. 

According to a study, hydrochlorothiazide has photosensitizing properties, meaning it makes the skin more sensitive to ultraviolet (UV) radiation. This occurs because the drug produces free radicals and reactive oxygen species when UV light penetrates the skin. These reactive molecules damage cell DNA and increase mutations in regulators like p53 and CDKN2A, which are key in controlling the cell cycle. Such mutations can accumulate and cause permanent UV injury, raising the risk of neoplastic changes in skin cells.

Another study further explained that these free radicals generated under sun exposure are central in how HCTZ affects skin health. Over time, they drive keratinocyte damage that can progress into keratinocyte carcinoma. Hydrochlorothiazide’s photosensitivity does not just heighten cancer risk. It can also trigger inflammatory skin responses, such as photoallergic and phototoxic reactions. These reactions may look like eczema or dermatitis, especially in areas exposed to light.

What skin conditions can appear?

Hydrochlorothiazide has been linked to a wide range of skin problems. These can vary from rashes and sunburn-like reactions to serious autoimmune issues. 

Below are the main conditions described in the studies.

  1. Hydrochlorothiazide-induced dermatitis

One study reported a striking case of a woman in her 60s who developed a bilateral erythematous rash across her legs, chest, and abdomen soon after starting hydrochlorothiazide. This was identified as hydrochlorothiazide-induced dermatitis, which is rare but distressing. The patient experienced pain, itching, fatigue, and poor sleep, all of which interfered with her daily life. Symptoms fully resolved only when hydrochlorothiazide was stopped.

  1. Photosensitivity and sunburn reactions

One study showed that thiazides, including HCTZ, have been associated with chronic photosensitivity. Patients can develop exaggerated sunburns even after modest exposure. Another study described how hydrochlorothiazide worsened photosensitivity in a psoriasis patient undergoing UVB therapy, proving the drug can amplify reactions to light.

  1. Eczematous and lichenoid eruptions

The same study above noted that hydrochlorothiazide may trigger widespread eczematous lesions with scaling, redness, and lichenification. These eruptions often spread beyond initial sites and can be mistaken for other skin conditions. They may persist unless the drug is discontinued.

  1. Drug-induced lupus

One study presented a case of hydrochlorothiazide-induced systemic lupus erythematosus. Patients developed systemic symptoms like fatigue and chest pain alongside rashes. Hydrochlorothiazide can trigger drug-induced lupus with antibodies such as ANA, anti-histone, and anti-dsDNA appearing in blood tests.

  1. Chronic rash and hypersensitivity reactions

One research described thiazide-associated rashes as rare but significant. Abdelwahab and colleagues highlighted that some patients may develop delayed drug hypersensitivity after years of safe use, suddenly reacting with widespread dermatitis. 

These rashes are not well-defined and can resemble contact dermatitis, making diagnosis challenging.

Does HCTZ use increase skin cancer risk?

The evidence here is complex. Some studies show a clear link, while others suggest only a modest or uncertain risk.

One study analyzed three large U.S. cohorts with over 3.5 million individuals. They compared hydrochlorothiazide to ACE inhibitors and found no clear or consistent increase in melanoma or non-melanoma skin cancer risk. For example, the hazard ratio for nonmelanoma skin cancer was 0.96 in the commercial cohort and 1.33 in Medicaid. 

For melanoma, hazard ratios ranged from 0.85 to 1.07, none of which reached statistical significance. Their conclusion was that race and other risk factors matter, and there was no definitive link across all groups.

In contrast, another study in Wisconsin found that each additional year of HCTZ use raised the odds of non-melanoma skin cancer by 14% under low sun exposure. The effect was even more pronounced in older adults with high sun exposure, where risk increased significantly after age 70.

Another study pooled nine observational studies in a meta-analysis. They found that thiazide diuretics, especially HCTZ, were associated with an increased risk of squamous cell carcinoma. The risk for basal cell carcinoma and melanoma was weaker but still present. Similarly, 50% increased risk of cutaneous squamous cell carcinoma among HCTZ users, especially in women.

The U.S. Food and Drug Administration also weighed in. Using its Sentinel Initiative, it reported that HCTZ is tied to a small but real increase in non-melanoma skin cancer, especially squamous cell carcinoma. They calculated about one additional SCC case per 16,000 patients per year. Though the risk is considered small, it was important enough for the FDA to mandate drug label changes and safety warnings.

How can patients protect themselves outdoors?

Hydrochlorothiazide makes the skin more sensitive to the sun. That fact alone changes how patients must approach outdoor activities. Studies and safety warnings highlight several key strategies to keep the skin safe.

  1. Use sunscreen correctly

The U.S. Food and Drug Administration emphasized that sunscreen is the first line of defense. They recommend broad-spectrum products with SPF 15 or higher. A thin layer is not enough. It must be applied generously, and it must be reapplied every couple of hours.

  1. Wear protective clothing

Clothing provides a second layer of defense. Long-sleeved shirts, long pants, and wide-brimmed hats shield the body from harmful rays. Sunglasses protect the eyes, which are also sensitive to UV damage.

This advice is particularly vital for people who cannot easily limit outdoor time. Gardeners, farmers, or postal workers are exposed daily. For them, fabric barriers may matter more than sunscreen because they don’t wear off. A wide-brimmed hat alone can lower exposure to the face and neck by nearly one-third.

  1. Limit time in the sun

The midday sun is the harshest. Between 10 a.m. and 4 p.m., UV radiation peaks. Staying indoors or seeking shade during those hours dramatically reduces exposure.

What does this mean in practice? 

Even shaving off two hours of peak sunlight per day adds up. Over a year, that’s hundreds of hours avoided. For hydrochlorothiazide users, those hours could make the difference between healthy skin and recurring burns.

  1. Schedule regular skin checks

Patients should have routine skin assessments. These checkups don’t need to be lengthy. A primary care doctor or dermatologist can often spot early warning signs in a matter of minutes.

  1. Respond quickly to skin reactions

The same study above described a patient who developed painful, itchy rashes soon after starting hydrochlorothiazide. She struggled with sleep and daily activities until the drug was stopped. Within weeks, the rash disappeared.

If you notice new rashes, patches, or itching after starting hydrochlorothiazide, do not wait. Contact a healthcare provider right away. Early recognition means faster recovery. Waiting only makes the outcome worse.

  1. Consider lifestyle and sun habits

The same study above found that patients who combined long-term hydrochlorothiazide use with high sun exposure, particularly those over 70, faced the greatest risks. This group included farmers, construction workers, and others who spent most of their day outdoors.

Lifestyle, then, cannot be ignored. A patient who jogs in the evening faces less danger than someone roofing under midday sun. The same drug interacts differently depending on daily routines.

That means prevention is not one-size-fits-all. Some may get by with sunscreen and a hat. Others, especially high-exposure workers, need every tool: shade, clothing, sunscreen, and medical follow-ups. These layered defenses reduce the compounded risks from both the drug and the sun.

Final words

Hydrochlorothiazide is a trusted medicine for blood pressure, but it changes how skin responds to sunlight. Even small amounts of sun can trigger stronger burns, rashes, or long-lasting irritation. In some cases, the risks go deeper, leading to conditions like dermatitis, lupus, or even higher chances of skin cancer.

Yet, with care, these risks can be lowered. Sunscreen, protective clothing, wide-brimmed hats, shade, and regular skin checks all work together to protect you. Paying attention to new skin changes and acting quickly matters most. 

Frequently asked questions

What is hydrochlorothiazide used for?

It helps treat high blood pressure and swelling (edema) caused by heart, liver, or kidney problems.

How does hydrochlorothiazide work?

It’s a “water pill” that makes you pee more, reducing extra fluid and lowering blood pressure.

Can kids take hydrochlorothiazide?

Safety for children isn’t well studied. A doctor must decide the dose if prescribed.

Is it safe for older adults?

Yes, but seniors may need lower doses since kidney, liver, or heart problems are more common.

Can I take it while breastfeeding?

It may affect milk production. Talk to your doctor before use if you’re breastfeeding.

Sources

  • Kumar, A., Priya, Khatri, G., Swed, S., & Hasan, M. M. (2022). Hydrochlorothiazide: A savior to the heart or a foe to the skin? Annals of Medicine and Surgery, 79, 103954. https://doi.org/10.1016/j.amsu.2022.103954
  • Adalsteinsson, J. A., Muzumdar, S., Waldman, R., Hu, C., Wu, R., Ratner, D., Ungar, J., Silverberg, J. I., Olafsdottir, G. H., Kristjansson, A. K., Tryggvadottir, L., & Jonasson, J. G. (2021). Association between hydrochlorothiazide and the risk of in situ and invasive squamous cell skin carcinoma and basal cell carcinoma: A population-based case-control study. Journal of the American Academy of Dermatology, 84(3), 669–675. https://doi.org/10.1016/j.jaad.2020.08.025
  • Abdelwahab, R., Tangalos, E. G., & Matulis, J. (2022). Differentiation of hydrochlorothiazide-induced dermatitis from stasis dermatitis. BMJ Case Reports, 15(9), e249884. https://doi.org/10.1136/bcr-2022-249884
  • Rosenthal, A., & Herrmann, J. (2019). Hydrochlorothiazide-induced photosensitivity in a psoriasis patient following exposure to narrow-band ultraviolet B excimer therapy. Photodermatology, Photoimmunology & Photomedicine, 35(5), 369–371. https://doi.org/10.1111/phpp.12471
  • Sosenko, T., Pasula, S., Brahmamdam, R., & Girnita, D. (2019). When chest pain reveals more: A case of hydrochlorothiazide-induced systemic lupus erythematosus. American Journal of Case Reports, 20, 26–30. https://doi.org/10.12659/AJCR.911380
  • Birck, M. G., Moura, C. S., Machado, M. A. A., Liu, J. L., Abrahamowicz, M., Pilote, L., & Bernatsky, S. (2023). Skin cancer and hydrochlorothiazide: Novel population-based analyses considering personal risk factors including race/ethnicity. Hypertension, 80(10), 21274. https://doi.org/10.1161/HYPERTENSIONAHA.123.2127
Posted in